Vhl 101 | Dr. Othon Iliopoulos, Md, Phd

VHL 101 | Dr. Othon Iliopoulos, MD, PhD

Advances in VHL Disease: Insights from Recent Research with Othon Iliopoulos, MD, PhD | Nov 2024

Natural History and Treatment of Hemangioblastomas in VHL | Othon Iliopoulos, MD, PhD

Welireg (Belzutifan) Q&A Session with Dr. Othon Iliopoulos

2020 International VHL Medical/Research Symposium: Othon Iliopoulos, MD, PhD

USO DEL BELZUTIFAN EN VHL DR OTHON ILIOPOULOS (HARVARD USA).

Systemic Therapy for Von Hippel-Lindau Associated Tumors | Ramaprasad Srinivasan, MD, PhD

VHLA Town Hall on Belzutifan (Welireg)

Unique Characteristics of VHL Pancreatic Tumors by Diagnostic Criteria | Reut Halperin, MD, PhD

Hypoxia Inducible Factor-2 (HIF-2) Inhibitor Belzutifan for VHL Treatment | Family Weekend 2024

VHLA Town Hall on Welireg

Belzutifan as a non-invasive treatment option for VHL-associated tumors

Practice Update: Updated Results of Belzutifan for Advanced RCC

The Mighty Compilation Video

Avery Latta-Raines story on welireg drug

Testing Treatments of Ocular Hemangioblastomas Associated with VHL | Emily Chew, MD

Inherited Kidney Cancer: Updates on Treatment and Living with Risk (2021)

MGHCancerCenter

FDA Approval of Belzutifan | Eric Jonasch, MD

Management of CNS Manifestations of VHL | Prashant Chittiboina, MD